Advice on vaccinating children and young people

The Joint Committee on Vaccination and Immunisation (JCVI) has advised this week that all 16 and 17-year-olds will receive their first dose of the Pfizer-BioNTech vaccine.
The updated advice means that young people will be afforded around 80% protection against hospitalisation, following their first dose.
It is expected that protection will probably be even higher as younger people respond better to vaccines and some will have already had the Covid-19 infection, meaning this first dose should act as a ‘booster’ to their immunity.
The second dose will extend protection for an even longer period, for example when those young people start work or go to university, or if we begin to get another wave of cases in winter. It is likely that, when the second dose is offered, this will be from 12 weeks after the first dose.